Medical Project

Aamena Javaid Chaudhry

** ********** *****, ******** ** 08873

Mobile: 732-***-****

Email: **************@*****.***

Professional Summery:

Seeking a challenging and career oriented position in the field of pharmacovigilance. Have hands

on comprehensive experience in gene delivery technology for applications in biotechnology and

pharmaceutical drug products. Performed routine analysis and conducted research on new

molecules.

Education:

University of Maryland, Baltimore County Fall 2004-Spring 2007

Bachelor of Science: Biology

WORK EXPERIENCE

May 2006 – July 2008 Research Associate, Research and Development, Lentigen,

Maryland, USA

Duties included using lentivector gene delivery technology for applications in biotechnology and

medicine. Responsible for cloning, Polymerase Chain Reactions (PCR) on DNA using gateway

technology,and infusion technology. Plasmid DNA isolation, transformation into E.coli XL 10

GoldCompetent Cells. Created vector backbones for particular plasmid constructs. Prepared

solutions and preps. Use of HPLC technique to purify substances. Drug dissolution testing.

Kept the laboratory clean and maintained a safe environment. Wrote and reviewed Standard

Operating Procedures for laboratory instruments. Updated laboratory notebook regularly.

Also worked on own project-

PROJECT: To Construct a Lentivirus Vector expressing eGFP as a Reporter

Gene.

METHODS: eGFP gene was PCR (Polymerse Chain Reaction) –amplified from

a commercially available peGFP plasmid, and cloned into a Lentiviral

vector under the control of SCMV(Simian CytoMegaloVirus) Promoter

by Gateway Technology, attB1-eGFP-attB2 PCR product was

recombined with a plasmid pDONR221, which has attP1-Negative

Selection Cassette-attP2 by an in vitro recombination reaction. The

product of this reaction (attL1-eGFP-attL2) was then used in a

second in vitro recombination reaction with a lentiviral vector containing

attR-1Negative Selection Cassette-attR2.

ADDITIONAL TRAINING

May –June 2013 The Veritas Healthcare Solutions

Regulations in Pharmacovigilance: FDA, ICH; Different sources of adverse events and various

adverse event reporting forms, factors for reportable case, seriousness criteria of adverse events,

causality assessment of adverse event, introduction to different safety databases, triage of cases,

hands on training on MedDRA, MedWatch, CIOMS, AERS; exercises for MedDRA coding

practice, document management/privacy/follow-up information obtaining and documenting for

ICSRs, pharmacovigilance event ranking/using the always serious list/rush cases card/upgrading

serious to non-serious, and non-serious to serious case, unifying a diagnosis/lack of effect/event

identification and upgrading adverse events/co-licensing partner process, multiple suspect

products/drug interaction/overdose, medical review process, line listing/PSURs/SUSAR processing,

case quality check, medical review and its submission, narrative writing on summary of cases.

OTHER EXPERIENCE:

May-August 2004 Intern, Cardiac Care, Annapolis, Maryland

Sept. 2004-May 2005 Volunteer, of Maryland Medical Systems, R. Adams

Cowley Shock Trauma Center

Sept. 2005-March 2006 Volunteer, University of Maryland Medical Center, Child

Life

Contact this candidate